Exalenz Bioscience Ltd.

Welcome to Exalenz

 

Exalenz Bioscience develops and markets advanced systems that extract vital information for diagnostics from subtle changes in patients’ exhaled breath, enabling medical specialists to identify and manage specific digestive and liver conditions at the point-of-care.

Liver

13C breath testing solutions for liver diseases
More

H. pylori

13C-urea solutions for detecting the Helicobacter pylori bacteria
More

Gastric Emptying

13C breath testing solutions for Gastric Emptying
More
2010 Exalenz Bioscience Ltd. All Rights Reserved
Developed by Moonsite

Disclaimer: In the USA, The BreathID System is intended for use in the qualitative detection of H. pylori. It has an approved 510(K) and an approved NDA for the 13 C-urea Tablet and Citrica Powder . Other applications are limited by Federal (of United States) Law to Investigational Use only. In Europe: The BreathID System has a CE approval for assessing Helicobacter pylori, Liver Function, and Gastric Emptying Rate.